Induction of CYP3A by ethanol in multiple in vitro and in vivo models

被引:45
作者
Feierman, DE [1 ]
Melinkov, Z [1 ]
Nanji, AA [1 ]
机构
[1] Mt Sinai Med Ctr, Dept Anesthesiol, New York, NY 10029 USA
关键词
enzymes; liver; microsomes; P-450; CYP3A;
D O I
10.1097/01.ALC.0000071738.53337.F4
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Cytochrome P-450 3A (CYP3A) is responsible for the metabolism of numerous therapeutic agents. The content of CYP3A seems to be affected by ethanol ingestion. Because ethanol is used widely, its potential interaction with CYP3A is of great interest. The effects of ethanol on CYP3A content and activity were assessed in different in vivo and in vitro models. Methods: Rats fed either the Lieber-DeCarli ethanol-containing diet or an ethanol and liquid diet via the intragastric tube feeding method were used. Additionally, HepG2 cell lines that constitutively and stably express human CYP3A4 were constructed to study ethanol interactions with CYP3A4. Results: In all models tested, ethanol induced CYP3A activity and content, as assessed by the metabolism of fentanyl, a sensitive and specific CYP3A substrate, and Western blot analysis, respectively. In the CYP3A4-expressing HepG2 cell line, incubation with ethanol caused a dose-dependent increase in CYP3A4 activity. Ethanol also increased messenger RNA levels of CYP3A4. In the HepG2-CYP3A4 line, incubation with cycloheximide caused a decrease in fentanyl metabolism secondary to a decrease in CYP3A4 levels; this decrease was prevented by coincubation of cycloheximide with ethanol. Conclusions: Ethanol induced CYP3A activity and content both in vitro and in vivo. There may be multiple mechanisms of induction of CYP3A4 by ethanol, including stabilization of messenger RNA and protein. Ethanol-induced increases in both the protein level and activity of CYP3A4 may play a role that might be of pathophysiological or clinical significance.
引用
收藏
页码:981 / 988
页数:8
相关论文
共 55 条
[21]   Identification of the enzyme responsible for oxidative halothane metabolism: Implications for prevention of halothane hepatitis [J].
Kharasch, ED ;
Hankins, D ;
Mautz, D ;
Thummel, KE .
LANCET, 1996, 347 (9012) :1367-1371
[22]  
KHARASCH ED, 1993, ANESTH ANALG, V76, P1033
[23]  
KOCAREK TA, 1995, DRUG METAB DISPOS, V23, P415
[24]   Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites [J].
Korzekwa, KR ;
Krishnamachary, N ;
Shou, M ;
Ogai, A ;
Parise, RA ;
Rettie, AE ;
Gonzalez, FJ ;
Tracy, TS .
BIOCHEMISTRY, 1998, 37 (12) :4137-4147
[25]   Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity [J].
Kostrubsky, VE ;
Szakacs, JG ;
Jeffery, EH ;
Wood, SG ;
Bement, WJ ;
Wrighton, SA ;
Sinclair, PR ;
Sinclair, JF .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 143 (02) :315-323
[26]   ETHANOL AND ISOPENTANOL INCREASE CYP3A AND CYP2E IN PRIMARY CULTURES OF HUMAN HEPATOCYTES [J].
KOSTRUBSKY, VE ;
STROM, SC ;
WOOD, SG ;
WRIGHTON, SA ;
SINCLAIR, PR ;
SINCLAIR, JF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 322 (02) :516-520
[27]  
Kostrubsky VE, 1997, ANN CLIN LAB SCI, V27, P57
[28]  
KRIKUN G, 1986, J PHARMACOL EXP THER, V237, P1012
[29]   CYCLOSPORINE METABOLISM IN HUMAN-LIVER - IDENTIFICATION OF A CYTOCHROME-P-450III GENE FAMILY AS THE MAJOR CYCLOSPORINE-METABOLIZING ENZYME EXPLAINS INTERACTIONS OF CYCLOSPORINE WITH OTHER DRUGS [J].
KRONBACH, T ;
FISCHER, V ;
MEYER, UA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (06) :630-635
[30]  
KRONBACH T, 1989, MOL PHARMACOL, V36, P89